FDC Limited has informed the Exchange regarding a press release dated July 12, 2021, titled "Press Release issued in relation to Launch of'India's first Favipiravir Oral Suspension - Favenza' meant to treat mild to moderate cases of Covid 19".
Press Release Jul 12 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from FDC
- Press Release May 27 2021
- Press Release Feb 06 2021
- Press Release Nov 11 2020
- Press Release Oct 30 2020
- Press Release Aug 25 2020
Later from FDC
- Press Release Aug 13 2021
- Press Release Nov 12 2021
- Buyback
- Press Release Feb 10 2022
- Press Release May 26 2022
Follow FDC into a list and get an email when it puts out news.
Follow FDC